Digenio Andres G, Mancuso James P, Gerber Robert A, Dvorak Roman V
Pfizer, South Lyme, Connecticut, USA.
Ann Intern Med. 2009 Feb 17;150(4):255-62. doi: 10.7326/0003-4819-150-4-200902170-00006.
Physicians frequently prescribe medications for weight loss but offer minimal lifestyle counseling despite the additional benefits of combining both interventions.
To compare 5 methods of delivering a lifestyle modification program to obese patients receiving sibutramine.
Randomized, 6-month, open-label study. Participants were assigned to intervention groups by using a computer-generated schedule of randomly permuted blocks. Block length was 5.
12 independent research clinics with experience running obesity trials.
376 patients with obesity (body mass index > or =30 and <40 kg/m(2)).
High-frequency face-to-face lifestyle modification counseling (HF-F2F) (n = 74), low-frequency face-to-face counseling (LF-F2F) (n = 76), high-frequency telephone counseling (HF-TEL) (n = 76), high-frequency e-mail counseling (HF-EMAIL) (n = 74), or no dietitian contact (self-help [SELF]) (n = 76). All participants received sibutramine, 10 mg/d; a lifestyle manual; and access to a weight-loss Web site.
Percentage change in body weight at 6 months was the primary outcome. Secondary end points included changes in waist circumference; lipid, glucose, and insulin levels; blood pressure; weight-related symptoms; and quality of life at 6 months.
At 6 months, the mean weight loss, relative to baseline, in the HF-F2F and HF-TEL groups was similar (8.9% [95% CI, 8.0% to 9.8%] and 7.7% [CI, 6.8% to 8.7%]) and significantly greater than that in the other groups (LF-F2F, 6.4% [CI, 5.4% to 7.3%]; HF-EMAIL, 5.9% [CI, 5.0% to 6.8%]; and SELF, 5.2% [CI, 4.3% to 6.1%]). All groups showed significant improvements in waist circumference, high-density lipoprotein cholesterol and triglyceride levels, and measures of quality of life and weight-related symptoms. There were no serious adverse events and no differences in minor events among groups.
Most participants were women, and the attrition rate was 30%.
High-frequency telephone contact with a dietitian was similar to HF-F2F contact for supporting lifestyle modification in obese patients trying to lose weight. The findings might be used by providers and health systems to promote healthy lifestyle changes for their patients.
Pfizer Global Research and Development.
医生经常开减肥药,但尽管将两种干预措施结合起来会带来更多益处,却很少提供生活方式咨询。
比较向服用西布曲明的肥胖患者提供生活方式改变计划的5种方法。
随机、为期6个月的开放标签研究。使用计算机生成的随机排列区组时间表将参与者分配到干预组。区组长度为5。
12家有肥胖试验经验的独立研究诊所。
376例肥胖患者(体重指数≥30且<40kg/m²)。
高频面对面生活方式改变咨询(HF-F2F)(n = 74)、低频面对面咨询(LF-F2F)(n = 76)、高频电话咨询(HF-TEL)(n = 76)、高频电子邮件咨询(HF-EMAIL)(n = 74)或无营养师接触(自助[SELF])(n = 76)。所有参与者均接受西布曲明,10mg/天;一本生活方式手册;以及访问一个减肥网站。
6个月时体重的百分比变化是主要结局。次要终点包括腰围、血脂、血糖和胰岛素水平、血压、与体重相关的症状以及6个月时的生活质量变化。
6个月时,HF-F2F组和HF-TEL组相对于基线的平均体重减轻相似(分别为8.9%[95%CI,8.0%至9.8%]和7.7%[CI,6.8%至8.7%]),且显著大于其他组(LF-F2F组为6.4%[CI,5.4%至7.3%];HF-EMAIL组为5.9%[CI,5.0%至6.8%];SELF组为5.2%[CI,4.3%至6.1%])。所有组在腰围、高密度脂蛋白胆固醇和甘油三酯水平以及生活质量和与体重相关症状的测量指标方面均有显著改善。未发生严重不良事件,组间轻微事件也无差异。
大多数参与者为女性,损耗率为30%。
对于试图减肥的肥胖患者,与营养师进行高频电话接触在支持生活方式改变方面与高频面对面接触相似。这些发现可供医疗服务提供者和卫生系统用于促进其患者的健康生活方式改变。
辉瑞全球研发部。